<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01905397</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00045975</org_study_id>
    <nct_id>NCT01905397</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy to Reduce Surgical Site Infection</brief_title>
  <official_title>Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kinetic Concepts, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the rate of surgical site infection between
      traditional wound care and negative pressure wound therapy. Wounds will be assessed 4-5 days
      after surgery and at the first clinic visit after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Surgical Site Infection</measure>
    <time_frame>30 days post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization of surgical site infection</measure>
    <time_frame>30 days post-surgery</time_frame>
    <description>Characterize the incidence of SSI as superficial incisional, deep incisional, and organ/space as defined by The American College of Surgeons NSQIP (National Surgical Quality Improvement Program) guidelines.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>30 days post-surgery</time_frame>
    <description>Assess (or compare) the length of hospital stay between subjects who receive standard of care and incisional V.A.C. via PIMS.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Patients Undergoing Hepatopancreatobiliary Surgery</condition>
  <arm_group>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Prevena Incision Management System is a 510K cleared device that covers and protects the incision from external infectious sources, while negative pressure removes fluid and infectious material from the surgical incision. The ActiVAC pump (also 510K cleared) may be used in some cases with the Prevena dressings as to achieve the negative pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional wound therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional wound therapy (sterile bandages and dressing)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional wound therapy</intervention_name>
    <description>Sterile bandages and wound coverings</description>
    <arm_group_label>Conventional wound therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative pressure wound therapy</intervention_name>
    <description>The Prevena Incision Management System covers and protects the incision from external infectious sources, while negative pressure removes fluid and infectious material from the surgical incision. The ActiVAC pump may be used with the Prevena dressings as well in some situations to achieve negative pressure.</description>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <other_name>Prevena Incision Management System; ActiVAC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female and male patients 18 years of age or older

          -  Scheduled for an elective surgery in either open CRS or open HPBS. This includes, but
             is not limited to: ileocecectomy, right hemicolectomy, extended right hemicolectomy,
             transverse colectomy, left hemicolectomy, sigmoidectomy, proctectomy, low anterior
             resection, or abdominoperineal resection gastrectomy, hepatectomy, bile duct
             reconstruction, duodenectomy, pancreatectomy, pancreaticoduodenectomy, or pancreatic
             duct reconstruction

        Exclusion Criteria:

          -  The need for emergency surgery.

          -  The need for use of only laparoscopic surgery.

          -  Presence of bowel obstruction, strangulation, peritonitis or perforation.

          -  The presence of local or systemic infection preoperatively.

          -  ASA class â‰¥4.

          -  Inability to provide informed consent and authorization.

          -  Known allergy or hypersensitivity to silver.

          -  Any clinically significant condition that, in the investigator's opinion, would
             significantly impair the subject's ability to comply with the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Trey Blazer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Bolch</last_name>
    <phone>919-668-6359</phone>
    <email>emily.bolch@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Mott</last_name>
      <email>lmott@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Ceppa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Amara, MSW</last_name>
      <phone>919-668-1861</phone>
      <email>Anthony.Amara@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Wanda Honeycutt, RN</last_name>
      <phone>919-668-1861</phone>
      <email>Wanda.Honeycutt@duke.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dan Blazer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 18, 2013</study_first_submitted>
  <study_first_submitted_qc>July 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2013</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

